ADMA Biologics, Inc. (ADMA)
20.39
+0.41
(+2.05%)
USD |
NASDAQ |
Dec 11, 16:00
20.39
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Research and Development Expense (TTM): 3.776M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Vanda Pharmaceuticals, Inc. | 100.10M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Arcutis Biotherapeutics, Inc. | 71.08M |
| Exelixis, Inc. | 860.76M |